Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.5299
-0.0004 (-0.08%)
At close: Jul 8, 2026, 4:00 PM EDT
0.5653
+0.0354 (6.68%)
After-hours: Jul 8, 2026, 7:55 PM EDT

Lexaria Bioscience Income Statement

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Revenue
0.370.710.460.230.260.72
Revenue Growth (YoY)
-30.03%52.05%105.24%-11.43%-64.66%129.59%
Cost of Revenue
-000.030.070.18
Gross Profit
0.370.70.460.190.180.55
Selling, General & Admin
4.094.353.853.064.964.97
Research & Development
5.758.242.363.671.841.26
Total Operating Expenses
9.8312.586.216.736.86.23
Operating Income
-9.46-11.88-5.75-6.53-6.62-5.69
Interest Income
000.010.04--
Other Non-Operating Income (Expense)
-0.07-0.03-0.07-0.22-0.761.52
Total Non-Operating Income (Expense)
-0.07-0.03-0.06-0.18-0.761.52
Pretax Income
-3.05-11.91-5.81-6.71-7.38-4.16
Net Income
-3.05-11.91-5.81-6.71-7.38-4.16
Minority Interest in Earnings
0.010.010.010.050.110.16
Earnings From Discontinued Operations
------0.02
Net Income to Common
-9.53-11.9-5.8-6.66-7.27-4.03
Shares Outstanding (Basic)
211812764
Shares Outstanding (Diluted)
211812764
Shares Change (YoY)
31.29%45.34%87.24%12.38%34.02%58.34%
EPS (Basic)
-0.47-0.66-0.47-1.01-1.24-0.95
EPS (Diluted)
-0.47-0.66-0.47-1.01-1.24-0.95
Free Cash Flow
-9.42-10.48-5-5.91-4.93-3.99
Free Cash Flow Per Share
-0.45-0.58-0.40-0.89-0.84-0.91
Gross Margin
100.00%99.61%98.96%86.07%71.87%75.74%
Operating Margin
-2571.89%-1683.01%-1239.16%-2888.50%-2591.67%-786.85%
Profit Margin
-827.68%-1687.36%-1251.12%-2967.41%-2891.05%-576.16%
FCF Margin
-2558.49%-1483.88%-1077.38%-2614.84%-1929.75%-552.02%
EBITDA
-9.38-11.79-5.68-6.39-6.52-5.58
EBITDA Margin
-2547.89%-1670.57%-1222.75%-2824.23%-2551.45%-771.39%
EBIT
-9.46-11.88-5.75-6.53-6.62-5.69
EBIT Margin
-2571.89%-1683.01%-1239.16%-2888.50%-2591.67%-786.85%
SEC Filings: 10-K · 10-Q